Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu
  • quotes

  • charts

  • technicals

  • company

Lexington Biosciences Inc (LXGTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1671 +4.73%
on 07/18/18
0.2350 -25.53%
on 06/27/18
-0.0350 (-16.67%)
since 06/19/18
3-Month
0.1401 +24.91%
on 06/07/18
0.3452 -49.30%
on 04/20/18
-0.1654 (-48.59%)
since 04/19/18
52-Week
0.1401 +24.91%
on 06/07/18
0.4844 -63.87%
on 12/11/17
-0.1232 (-41.31%)
since 07/19/17

Most Recent Stories

More News
Lexington Biosciences Announces Results of Annual General Meeting

Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, wishes to provide the results of its recent Annual General Meeting.

LNB.CN : 0.240 (unch)
LXGTF : 0.1750 (-5.35%)
Lexington Biosciences Concludes Initial HeartSentry Clinical Study

Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to announce the completion of the initial HeartSentry study conducted...

LNB.CN : 0.240 (unch)
LXGTF : 0.1750 (-5.35%)
Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

LNB.CN : 0.240 (unch)
LXGTF : 0.1750 (-5.35%)
Lexington Engages with Major Canadian University and Provides Clinical Trial Update

Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to advise it has engaged with a dedicated research team at The...

LNB.CN : 0.240 (unch)
LXGTF : 0.1750 (-5.35%)
Lexington Announces Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

LNB.CN : 0.240 (unch)
LXGTF : 0.1750 (-5.35%)
Lexington Releases Audited Consolidated Financial Statements

Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, has released its audited Consolidated Financial Statements and Management,...

LNB.CN : 0.240 (unch)
LXGTF : 0.1750 (-5.35%)
Lexington Begins HeartSentry Clinical Trial

Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to announce commencement of its clinical trial and first patient...

LNB.CN : 0.240 (unch)
LXGTF : 0.1750 (-5.35%)
2 Medical Stocks Trending on Today's News

CORAL GABLES, FL / ACCESSWIRE / February 13, 2018 / Medical, biotech, and pharmaceutical stocks have been trending higher since President Trump came into office. In his first year following the inauguration,...

LXGTF : 0.1750 (-5.35%)
Lexington Delivers 1st Generation HeartSentry for Clinical Trials

Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to advise that its HeartSentry 1 generation product has successfully...

LNB.CN : 0.240 (unch)
LXGTF : 0.1750 (-5.35%)
Lexington Recieves Approval to Commence Clinical Study

Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to announce its recent application for Institutional Review Board...

LNB.CN : 0.240 (unch)
LXGTF : 0.1750 (-5.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade LXGTF with:

Key Turning Points

2nd Resistance Point 0.1936
1st Resistance Point 0.1843
Last Price 0.1750
1st Support Level 0.1666
2nd Support Level 0.1582

See More

52-Week High 0.4844
Fibonacci 61.8% 0.3529
Fibonacci 50% 0.3123
Fibonacci 38.2% 0.2716
Last Price 0.1750
52-Week Low 0.1401

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar